EXAGEN INC. - COMMON STOCK

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD

12 ديسمبر 2024 09:00:00 بحسب Nasdaq GlobeNewswire

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform

14 نوفمبر 2024 16:30:00 بحسب Nasdaq GlobeNewswire

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

13 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Exagen Inc. Reports Third Quarter 2024 Results

12 نوفمبر 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Exagen to Announce Third Quarter 2024 Results on November 12, 2024

29 أكتوبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence

21 أكتوبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference

04 سبتمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance

05 أغسطس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference

02 أغسطس 2024 09:00:00 بحسب Nasdaq GlobeNewswire

Exagen Appoints Jeffrey G. Black as New Chief Financial Officer

01 أغسطس 2024 09:00:00 بحسب Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2024 Results on August 5, 2024

22 يوليو 2024 09:00:00 بحسب Nasdaq GlobeNewswire

Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year

13 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Exagen Announces Campaign for Lupus Awareness Month

06 مايو 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Exagen to Announce First Quarter 2024 Results on May 13, 2024

30 أبريل 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Exagen Inc. Announces Changes to the Board of Directors

26 أبريل 2024 08:30:00 بحسب Nasdaq GlobeNewswire

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results

18 مارس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

08 مارس 2024 09:00:00 بحسب Nasdaq GlobeNewswire

Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024

07 مارس 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

30 يناير 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance

07 يناير 2024 12:00:00 بحسب Nasdaq GlobeNewswire